In our recent webinar, Flip the switch: why you should turn on digital drug testing, our experts Denise Mullins, senior technical product development manager, Ryan Osborn, technical product development manager, and Anthony Magazzolo, technical product development manager, highlighted the value of adopting digital solutions for workplace drug testing. Paper record keeping may linger indefinitely, but utilizing electronic Custody and Control Forms (eCCF) can help to streamline the employer drug testing process today.
Key advantages of making the switch to eCCF from paper forms
- When comparing 95th percentiles on in-lab turnaround time (receipt to report), General U.S. workforce urine drug test specimens collected using eCCF were reported 7.5 or more hours sooner than those collected using traditional paper custody and control form in 2018.
- Following the analysis of our General U.S. workforce urine drug testing specimens in 2018, those collected using paper CCFs were nearly 8.5x more likely to be delayed in the laboratory for a Test in Question (TIQ) than those collected on an electronic CCF.1
- In 2018 our data indicate that General U.S. workforce urine specimens collected on traditional paper CCFs had a greater than 5x higher likelihood of having a fatal flaw than specimens collected on an eCCF.2
Why switch to electronic Custody And Control Forms? see more facts and data about the advantages of eCCF, download our case study titled, Paper is the past, step into digital drug testing with eCCF.
A recent example of the immediate benefits of electronic forms took place when the Federal government altered the CCF requirements in 2018. A company using eCCF were largely unaffected by the change and had the most current version of their eCCF with no action required. On the other hand, companies using paper forms had to manage their outdated inventory of forms, get new forms by mail, all while ensuring the proper forms were being used for their drug test collections. a CCF change in the collection sites, and ensuring that the proper forms are being used. Delays and disruption to the workflow are likely inevitable.
“Digital solutions make sense, in our personal lives and with the companies we interact with. Switching to eCCF fits just as well, drug testing doesn’t have to be difficult and using electronic solutions can make the whole process more consistent, efficient, and most importantly, paper-free.” Anthony Magazzolo, technical product development manager, Quest Diagnostics.
One of the most critical portions of the drug testing process is the collection of the specimen. In an industry where regulations and requirements mandate the safekeeping of sensitive data, the use of a digital solution like eCCF can help make a multi-step process more efficient. This webinar encourages employers to switch to eCCF, and in doing so to bring their drug testing program into the digital age.
To learn more about eCCF, visit our website.
1 TIQs are recoverable flaws in the collection process, which do not stop testing, but do affect overall turnaround time from collection to report of the specimen.
2 Fatal flaws are non-recoverable flaws, which halt the testing process and a re-collect is the only solution.